You have access
Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition
JONG SEUNG LIM, YUJIN PARK, BYUNG MU LEE, HYUNG SIK KIM and SUNGPIL YOON
Anticancer Research October 2016, 36 (10) 5063-5070;
